Skip to content

Ikonisys vs RareCyte, Inc.

Ikonisys logo

Ikonisys

Finding the cells that matter

39 employees · est. 1999 · France

VS
RareCyte, Inc. logo

RareCyte, Inc.

A one-stop resource for Spatial Biology and Liquid Biopsy solutions

65 employees · est. 2009 · Seattle, United States

Ikonisys is the older company (1999 vs 2009); RareCyte, Inc. is the larger of the two.

Side-by-Side Comparison

Ikonisys RareCyte, Inc.
Founded
1999 older 2009
Headquarters
France Seattle, United States
Employees
39 65 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care, Medical Devices
Funding Stage
Post-IPO Equity Venture round
Total Funding
$50.06M $96.00M
Funding Rounds
9 6
Services
Fluorescence In Situ Hybridization Technology, Automated Cancer Diagnostics, Rare Cell Detection, Microscope Slide Analysis, Genetic Testing Platform Not tracked yet
Target Customers
Oncology Diagnostic Labs, Pathologists, Healthcare Professionals, Medical Researchers, Biomedical Engineers Not tracked yet
Taxonomy
Rare Cell DetectionCancer DiagnosticsCTCLiquid BiopsyMedical TechnologyFluorescence Microscopy +8 Spatial BiologyLiquid BiopsyRareCytePrecision BiologyOncologyImmuno-oncology +9
Website
ikonisys.com rarecyte.com
Ikonisys logo

About Ikonisys

is a biotechnology startup based in France that is revolutionizing diagnostic medicine with its focus on early, accurate, and non-invasive disease detection. Its breakthrough fluorescence microscopy platform, Ikoniscope20®, is a robotic, high-throughput system that provides a walk-away automated so...

RareCyte, Inc. logo

About RareCyte, Inc.

RareCyte, Inc. is a prominent player in the field of Spatial Biology and Liquid Biopsy solutions, offering a comprehensive range of services to leaders across Research, Translational Medicine, and the Clinic. Headquartered in Seattle, WA, the company has been at the forefront of developing innovativ...

Also comparing in this category

Comparing more than these two?

Get Ikonisys, RareCyte, Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Ikonisys compare?

A PDF of Ikonisys and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Ikonisys was founded in 1999, based in France, with 39 employees. is a biotechnology startup based in France that is revolutionizing diagnostic medicine with its focus on early, accurate, and non-invasive disease detection. Its breakthrough fluorescence microscopy p. RareCyte, Inc. was founded in 2009, based in Seattle, United States, with 65 employees. RareCyte, Inc. is a prominent player in the field of Spatial Biology and Liquid Biopsy solutions, offering a comprehensive range of services to leaders across Research, Translational Medicine, and the.
Ikonisys has raised $50.06M and RareCyte, Inc. $96.00M. Latest stage: Ikonisys Post-IPO Equity, RareCyte, Inc. Venture round.
Both work in Biotechnology and Health Care and list liquid biopsy among their focus areas.

Compare Ikonisys with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ikonisys on 7 Jun 2025, and RareCyte, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout